Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
https://syoparekisteri.fi/assets/files/2024/06/Cancer_2022_EN.pdf. Accessed 12 Apr 2024
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, et al. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(7):873–98.
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72.
Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371(9625):1695–709.
CAS PubMed PubMed Central Google Scholar
Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012;13(1):35–46.
Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol. 2010;21(Suppl 7):vii252–61.
Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer. 2000;36(8):1032–7.
Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, et al. Low-dose immunotherapy in head and neck cancer: a randomized study. J Clin Oncol. 2023;41(2):222–32.
Cohen EEW, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet. 2019;393(10167):156–67.
Park JO, Nam IC, Kim CS, Park SJ, Lee DH, Kim HB, et al. Sex differences in the prevalence of head and neck cancers: a 10-year follow-up study of 10 million healthy people. Cancers (Basel). 2022;14(10):2521.
CAS PubMed PubMed Central Google Scholar
Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 2020;102: 104551.
Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S198–207.
CAS PubMed PubMed Central Google Scholar
Ethunandan M, Rennie A, Hoffman G, Morey PJ, Brennan PA. Quality of dying in head and neck cancer patients: a retrospective analysis of potential indicators of care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(2):147–52.
Price KA, Moore EJ, Moynihan T, Price DL. Symptoms and terminal course of patients who died of head and neck cancer. J Palliat Med. 2009;12(2):117–8.
Lin YL, Lin IC, Liou JC. Symptom patterns of patients with head and neck cancer in a palliative care unit. J Palliat Med. 2011;14(5):556–9.
Schenker Y, Arnold RM, Bauman JE, Heron DE, Johnson JT. An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer. Cancer. 2016;122(3):340–3.
Weis J. Psychosocial care for cancer patients. Breast Care (Basel). 2015;10(2):84–6.
Balfe M, Keohane K, O’Brien K, Sharp L. Social networks, social support and social negativity: a qualitative study of head and neck cancer caregivers’ experiences. Eur J Cancer Care (Engl). 2017;26(6): e12619.
Lokker ME, Offerman MP, van der Velden LA, de Boer MF, Pruyn JF, Teunissen SC. Symptoms of patients with incurable head and neck cancer: prevalence and impact on daily functioning. Head Neck. 2013;35(6):868–76.
Makitie AA, Pukkila M, Laranne J, Pulkkinen J, Vuola J, Back L, et al. Oropharyngeal carcinoma and its treatment in Finland between 1995–1999: a nationwide study. Eur Arch Otorhinolaryngol. 2006;263(2):139–43.
Makitie AA, Koivunen P, Keski-Santti H, Tornwall J, Pukkila M, Laranne J, et al. Oral tongue carcinoma and its treatment in Finland. Eur Arch Otorhinolaryngol. 2007;264(3):263–7.
Koivunen P, Makitie AA, Back L, Pukkila M, Laranne J, Kinnunen I, et al. A national series of 244 sinonasal cancers in Finland in 1990–2004. Eur Arch Otorhinolaryngol. 2012;269(2):615–21.
Haapaniemi A, Koivunen P, Saarilahti K, Kinnunen I, Laranne J, Aaltonen LM, et al. Laryngeal cancer in Finland: a 5-year follow-up study of 366 patients. Head Neck. 2016;38(1):36–43.
Begbie FD, Douglas CM, Finlay F, Montgomery J. Palliative intent treatment for head and neck cancer: an analysis of practice and outcomes. J Laryngol Otol. 2019;133(4):313–7.
Talani C, Makitie A, Beran M, Holmberg E, Laurell G, Farnebo L. Early mortality after diagnosis of cancer of the head and neck—a population-based nationwide study. PLoS ONE. 2019;14(10): e0223154.
CAS PubMed PubMed Central Google Scholar
Boethius H, Saarto T, Laurell G, Farnebo L, Makitie AA. A Nordic survey of the management of palliative care in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 2021;278(6):2027–32.
Civantos AM, Prasad A, Carey RM, Bur AM, Mady LJ, Brody RM, et al. Palliative care in metastatic head and neck cancer. Head Neck. 2021;43(9):2764–77.
Haltia O, Vesinurm M, Leskela RL, Rahko E, Tyynela-Korhonen K, Lehto JT, et al. The effect of palliative outpatient units on resource use for cancer patients in Finland. Acta Oncol. 2023;62(9):1118–23.
Mayland CR, Ho QM, Doughty HC, Rogers SN, Peddinti P, Chada P, et al. The palliative care needs and experiences of people with advanced head and neck cancer: a scoping review. Palliat Med. 2021;35(1):27–44.
Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, et al. Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol. 2024;42(19):2336–57.
Henson LA, Higginson IJ, Gao W, BuildCare. What factors influence emergency department visits by patients with cancer at the end of life? Analysis of a 124,030 patient cohort. Palliat Med. 2018;32(2):426–38.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.
Scibetta C, Kerr K, McGuire J, Rabow MW. The costs of waiting: implications of the timing of palliative care consultation among a cohort of decedents at a comprehensive cancer center. J Palliat Med. 2016;19(1):69–75.
Kamisetty A, Magennis P, Mayland C, Jack B, Lowe D, Rogers SN. Where do patients treated for oral cancer die? A 20-year cohort study 1992–2011. Br J Oral Maxillofac Surg. 2015;53(10):1015–20.
Espeli VG, Fusi-Schmidhauser T, Mangan D, Gamondi C. The role of palliative care in relapsed and metastatic head and neck cancer patients in a single ESMO integrated oncology and palliative care centre. Eur Arch Otorhinolaryngol. 2022;279(12):5897–902.
Fullarton M, Pybus S, Mayland C, Rogers SN. Analysis of deaths between 2007 and 2012 of patients with cancer of the head and neck on a surgical ward at a regional centre and in an independent hospice. Br J Oral Maxillofac Surg. 2016;54(1):62–7.
Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017;35(8):834–41.
Comments (0)